Sunday, September 28, 2008
BLOGSCAN - Duplicate Publication about an SSRI
On the Clinical Psychology and Psychiatry Blog, the anonymous blogger described an interesting example of apparent dual publication on a selective serotonin reuptake inhibitor (SSRI) anti-depressant drug, duloxetine (Cymbalta, manufactured by Eli Lilly). Important aspects of the story include how both articles draw conclusions that go well beyond the (same) data in their enthusiasm for the drug in question, and how the second article incorporated an author not found in the first, an author who also happened to be the co-editor in chief of the journal in which the second article appeared, and the leader of an important medical society. This author has been the subject of previous posts (like this one), on Health Care Renewal.